|
Volumn 70, Issue 4, 1999, Pages 248-260
|
Long-term survival and prognostic study in acute promyelocytic leukemia treated with alRnrns-retinoic acid, chemotherapy, and As2O3: An experience of 120 patients at a single institution
|
Author keywords
Acute promyelocytic leukemia; All trans retinoic acid; Arsenic trioxide; Chemotherapy
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARSENIC TRIOXIDE;
ONCOPROTEIN;
ORGANOARSENIC DERIVATIVE;
OXIDE;
PROMYELOCYTIC LEUKEMIA RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN;
PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN;
RETINOIC ACID;
TUMOR PROTEIN;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CHILD;
CLINICAL TRIAL;
FEMALE;
FOLLOW UP;
HUMAN;
MALE;
MIDDLE AGED;
PROGNOSIS;
PROMYELOCYTIC LEUKEMIA;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SURVIVAL RATE;
ADOLESCENT;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ARSENICALS;
CHILD;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
MALE;
MIDDLE AGED;
NEOPLASM PROTEINS;
ONCOGENE PROTEINS, FUSION;
OXIDES;
PROGNOSIS;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
SURVIVAL RATE;
TRETINOIN;
|
EID: 0033254499
PISSN: 09255710
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (63)
|
References (1)
|